UroGen Pharma Ltd. URGN
Set alert
34.20 USD -0.16 -0.47%
As of Nov 3, 2:47 PM ET
34.00 Day range 34.97
16.50 52-week range 50.81
- YTD
- +46.03%
- 1 year
- +65.86%
- Open
- 34.50
- Prev close
- 34.36
- Mkt cap
- 1.67B
- Vol
- 700.49K
- Avg vol
- 964.75K
- EPS
- -1.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 34.00
- High
- 34.97
- Forward P/E
- 12.45
- Beta
- 1.64
- Short ratio
- 5.87
- Inst. own
- 98.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 40.44
- 200-d avg
- 31.31
- 1y target
- 60.00
5D chart
Signals (108)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 9:30 AM | 5 hours ago |
| SMA: Bullish | Nov 3, 9:30 AM | 5 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 3:50 PM | 22 hours ago |
| RSI: Overbought | Nov 2, 3:40 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:35 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:30 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 2:15 PM | 1 day ago |
| RSI: Overbought | Nov 2, 2:10 PM | 1 day ago |
| RSI: Overbought | Nov 2, 1:55 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:40 PM | 1 day ago |
| RSI: Overbought | Nov 2, 1:40 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:20 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:10 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:10 PM | 1 day ago |
| RSI: Overbought | Nov 2, 12:55 PM | 1 day ago |
| RSI: Overbought | Nov 2, 12:10 PM | 1 day ago |
| SMA: Bullish | Nov 2, 10:55 AM | 1 day ago |
Newest 20 of 108.
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 109.79M | 90.40M | 82.71M | 64.36M | 48.04M | |
| 97.34M | 81.52M | 73.35M | 56.70M | 42.88M | |
| -124.86M | -96.78M | -65.54M | -79.04M | -92.29M | |
| -153.49M | -126.87M | -102.24M | -109.78M | -110.82M | |
| -3.19 | -2.96 | -3.55 | -4.81 | -4.96 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 112.09M | 173.06M | 95.82M | 56.22M | 45.59M | |
| 200.46M | 285.71M | 178.31M | 135.62M | 119.75M | |
| 305.93M | 294.51M | 243.52M | 224.98M | 111.33M | |
| 130.09M | 123.39M | 99.39M | 99.12M | 398.00K | |
| -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -162.44M | -96.77M | -76.38M | -87.56M | -84.89M | |
| 61.56M | -20.61M | -953.00K | 1.06M | 4.07M | |
| 39.92M | 194.62M | 116.93M | 97.13M | 72.32M | |
| -289.00K | -295.00K | -194.00K | -254.00K | -752.00K | |
| -60.97M | 77.24M | 39.60M | 10.63M | -8.50M |